sábado, 30 de mayo de 2020

US pharma giant Gilead Sciences seeks marketing authorisation from India for remdesivir | coronavirus outbreak News,The Indian Express

US pharma giant Gilead Sciences seeks marketing authorisation from India for remdesivir | coronavirus outbreak News,The Indian Express

remdesivir, Coronavirus drug, Us giant company for remdesivir, Gilead Sciences, Gilead Sciences remdesivir, covid drug, Coronavirus treatment, Indian express

US pharma giant Gilead Sciences seeks marketing authorisation from India for remdesivir



Gilead Sciences, who is the patent holder of the drug, has the complete data about the pre-clinical and clinical studies for remdesivir, sources said. The medicine has been issued an Emergency Use Authorization (EUA) by the United States Food and Drug Administration (FDA) to treat hospitalised coronavirus patients.

No hay comentarios: